Aller au contenu principal
Accès ouvert déclaré 2026 article

Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans

1Citations signalées, ce qui n’est pas une note de qualité
6Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : kr, us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

CYP2D6-mediated drug-drug-gene interactions (DDGIs) are known to influence the pharmacokinetics of venlafaxine and its metabolism to O-desmethylvenlafaxine. Solanidine and 3,4-seco-solanidine-3,4-dioic acid (SSDA) have recently been investigated as candidate endogenous CYP2D6 biomarkers; however, they remain unexplored in East Asian populations, where dietary potato intake is relatively lower than that in Western populations. A prospective clinical study aimed to characterize venlafaxine DDGIs and explore the potential of solanidine as a candidate biomarker of CYP2D6 activity in healthy Korean adults. Twenty participants including 14 CYP2D6 normal metabolizers (NMs) and 6 intermediate metabolizers (IMs)-all confirmed as CYP2C19 NMs-were enrolled. Serial plasma samples for pharmacokinetic assessment were collected before and after coadministration of paroxetine, a potent CYP2D6 inhibitor. Solanidine and SSDA were also measured in plasma and urine. Compared to CYP2D6 NMs, IMs exhibited higher venlafaxine exposure but lower O-desmethylvenlafaxine exposure. Following CYP2D6 inhibition, phenotype-dependent differences in venlafaxine and O-desmethylvenlafaxine pharmacokinetics were attenuated. The metabolic ratio (MR) of plasma solanidine showed a modest positive correlation with both the MR of venlafaxine and CYP2D6 activity score. The MR of plasma solanidine decreased when CYP2D6 activity was reduced by paroxetine coadministration. These findings demonstrate phenotype-dependent DDGIs of venlafaxine and suggest the exploratory potential of solanidine as an endogenous biomarker of CYP2D6 activity in the Korean population, despite relatively lower dietary exposure to potato-derived precursors. This study provides preliminary evidence extending endogenous CYP2D6 biomarkers to an East Asian population with distinct dietary backgrounds.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
Exploratory Evaluation of Solanidine as an Endogenous Marker for <scp>CYP2D6</scp> ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans
Date Crossref
23/04/2026
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Pharmacogenetics and Drug MetabolismPotato Plant ResearchTryptophan and brain disorders

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.